HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

In vivo imaging of cell proliferation enables the detection of the extent of experimental rheumatoid arthritis by 3'-deoxy-3'-18f-fluorothymidine and small-animal PET.

AbstractUNLABELLED:
The aim of this work was to study the feasibility of measuring cell proliferation noninvasively in vivo during different stages of experimental arthritis using the PET proliferation tracer 3'-deoxy-3'-(18)F-fluorothymidine ((18)F-FLT).
METHODS:
We injected mice with serum containing glucose-6-phosphate-isomerase-specific antibodies to induce experimental arthritis, and we injected control mice with control serum. Animals injected with (18)F-FLT 1, 3, 6, and 8 d after the onset of disease were analyzed in vivo by PET, PET/CT, or PET/MR imaging followed by autoradiography analysis. The (18)F-FLT uptake in the ankles and forepaws was quantified on the basis of the PET images by drawing standardized regions of interest. To correlate the in vivo PET data with cell proliferation, we performed Ki-67 immunohistochemistry of diseased and healthy joints at the corresponding time points.
RESULTS:
Analysis of the different stages of arthritic joint disease revealed enhanced (18)F-FLT uptake in arthritic ankles (2.2 ± 0.2 percentage injected dose per gram [%ID/g]) and forepaws (2.1 ± 0.3 %ID/g), compared with healthy ankles (1.4 ± 0.3 %ID/g) and forepaws (1.5 ± 0.5 %ID/g), as early as 1 d after the glucose-6-phosphate-isomerase serum injection, a time point characterized by clear histologic signs of arthritis but only slight ankle swelling. The (18)F-FLT uptake in the ankles (3.5 ± 0.3 %ID/g) reached the maximum observed level at day 8. Ki-67 immunohistochemical staining of the arthritic ankles and forepaws revealed a strong correlation with the in vivo (18)F-FLT PET data. PET/CT and PET/MR imaging measurements enabled us to identify whether the (18)F-FLT uptake was located in the bone or the soft tissue.
CONCLUSION:
Noninvasive in vivo measurement of cell proliferation in experimental arthritis using (18)F-FLT PET is a promising tool to investigate the extent of arthritic joint inflammation.
AuthorsKerstin Fuchs, Ursula Kohlhofer, Leticia Quintanilla-Martinez, Denis Lamparter, Ina Kötter, Gerald Reischl, Martin Röcken, Bernd J Pichler, Manfred Kneilling
JournalJournal of nuclear medicine : official publication, Society of Nuclear Medicine (J Nucl Med) Vol. 54 Issue 1 Pg. 151-8 (Jan 2013) ISSN: 1535-5667 [Electronic] United States
PMID23213198 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Dideoxynucleosides
  • Ki-67 Antigen
  • Glucose-6-Phosphate Isomerase
  • alovudine
Topics
  • Animals
  • Arthritis, Rheumatoid (chemically induced, diagnostic imaging, metabolism, pathology)
  • Biological Transport
  • Cell Proliferation
  • Dideoxynucleosides (metabolism)
  • Feasibility Studies
  • Female
  • Gene Expression Regulation
  • Glucose-6-Phosphate Isomerase (adverse effects)
  • Ki-67 Antigen (metabolism)
  • Magnetic Resonance Imaging
  • Mice
  • Mice, Inbred BALB C
  • Multimodal Imaging
  • Positron-Emission Tomography
  • Tomography, X-Ray Computed

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: